Zobrazeno 1 - 10
of 1 341
pro vyhledávání: '"A, Muhammadnejad"'
Autor:
Muhammadnejad, Samad, Monzavi, Seyed Mostafa, Torabi-Rahvar, Monireh, Sotoudeh, Masoud, Muhammadnejad, Ahad, Tavakoli-Shiraji, Sahar, Ranjbar, Azam, Aghayan, Seyed Sajjad, Khorsand, Amir Arsalan, Moradzadeh, Kobra, Janzamin, Ehsan, Ahmadbeigi, Naser
Publikováno v:
In International Immunopharmacology January 2023 114
Autor:
Zeinab Ghazvinian, Shahrokh Abdolahi, Mohammad Ahmadvand, Amir Hossein Emami, Samad Muhammadnejad, Hamid Asadzadeh Aghdaei, Jafar Ai, Mohammad Reza Zali, Iman Seyhoun, Javad Verdi, Kaveh Baghaei
Publikováno v:
BioImpacts, Vol 13, Iss 5, Pp 383-392 (2023)
Introduction: Gastric cancer is one of the most commonly known malignancies and is the fifth cancer-related death globally. Whereas natural killer (NK) cells play a critical role in tumor elimination; therefore, adoptive NK cell therapy has become a
Externí odkaz:
https://doaj.org/article/fcec1d167ba944ea836236d46479d3a1
Autor:
Seyed Mostafa Monzavi, Amir Ali Hamidieh, Mohammad Vasei, Jafar Ai, Naser Ahmadbeigi, Hamid Arshadi, Samad Muhammadnejad, Abdol-Mohammad Kajbafzadeh
Publikováno v:
BioImpacts, Vol 13, Iss 5, Pp 415-424 (2023)
Introduction: T cells that recognize WT1 peptides have been shown to efficiently eliminate WT1-expressing tumor cells. This study was designed to investigate the feasibility of isolating WT1-reactive T cells from peripheral blood mononuclear cells (P
Externí odkaz:
https://doaj.org/article/34907f1782bf4400852d2dbb9b99be67
Publikováno v:
Veterinary Medicine International, Vol 2024 (2024)
Clinical and molecular similarities between canine mammary tumors (CMTs) and human breast cancer (HBC) propel scientists to further study their application in comparative oncology as a model for human breast cancer. In total, 64 canine mammary tumors
Externí odkaz:
https://doaj.org/article/ffaf175ba4a4411fbd2961418f223e70
Spontaneous xenogeneic GvHD in Wilms' tumor Patient‐Derived xenograft models and potential solutions
Autor:
Seyed Mostafa Monzavi, Ahad Muhammadnejad, Maryam Behfar, Amir Arsalan Khorsand, Samad Muhammadnejad, Abdol‐Mohammad Kajbafzadeh
Publikováno v:
Animal Models and Experimental Medicine, Vol 5, Iss 4, Pp 389-396 (2022)
Abstract Severely immunocompromised NOD.Cg‐PrkdcscidIl2rgtm1Sug (NOG) mice are among the ideal animal recipients for generation of human cancer models. Transplantation of human solid tumors having abundant tumor‐infiltrating lymphocytes (TILs) ca
Externí odkaz:
https://doaj.org/article/4dbb936ec9304f2ca0f839a1e6393061
Publikováno v:
Journal of Kerman University of Medical Sciences, Vol 30, Iss 1, Pp 51-54 (2023)
Background: Up-regulation of ribosome biogenesis encodes the factors related to carcinogenesis. It has been shown that the nucleus diameter and number of nucleoli increase from normal mucosa to oral squamous cell carcinoma (OSCC). The relationship be
Externí odkaz:
https://doaj.org/article/57127da7e07a4dbda42bc39db7669f15
Autor:
Masoud Bitaraf, Samad Muhammadnejad, Ashkan Azimzadeh, Saman Behboodi Tanourlouee, Erfan Amini, Masoumeh Majidi Zolbin, Abdol‐Mohammad Kajbafzadeh
Publikováno v:
Animal Models and Experimental Medicine, Vol 5, Iss 6, Pp 575-581 (2022)
Abstract Background Bladder cancer poses a great burden on society and its high rate of recurrence and treatment failure necessitates use of appropriate animal models to study its pathogenesis and test novel treatments. Orthotopic models are superior
Externí odkaz:
https://doaj.org/article/d46e9cfda528461eb2d8dda2069a7adb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Razavirad, Amirhossein1,2, Muhammadnejad, Ahad2, Soleymanjahi, Saeed1,3, Rismanchi, Sanaz, Saeedi, Elnaz1, Fallah, Amirafraz1, Abdollahi, Alireza4, Amanpour, Saeid2, Zendehdel, Kazem1 kzendeh@tums.ac.ir
Publikováno v:
Basic & Clinical Cancer Research. 2023, Vol. 15 Issue 2, p1-14. 14p.
Autor:
Saieh Hajighasemlou, Mohsen Nikbakht, Saeedreza Pakzad, Abdolnaser Azadbakht, Samad Muhammadnejad, Milad Mirmoghtadaei, Safoora Gharibzadeh, Iman Seyhoun, Javad Verdi
Publikováno v:
Veterinary Medicine and Science, Vol 8, Iss 5, Pp 2086-2091 (2022)
Abstract Background Hepatocellular carcinoma (HCC) is the fifth most diagnosed cancer and the second leading cause of cancer‐related deaths worldwide. Sorafenib is the standard treatment used in the advanced stages of HCC. Cell therapy with mesench
Externí odkaz:
https://doaj.org/article/1b62b91eeaa9473bb21a5f9ee1a899e2